Home

15 May 2012, London: Traditional medicines and their regulations - great line up of speakers

The Directors of Global Regulatory Services (GRS) are delighted to be involved the Asia-Pacific Technology Network (APTN) event being held at 17:00 in London on Tuesday 15th May:

http://www.aptn.org.uk/20122Q/120515%20Asian%20Medicines.html

Cosmetics: Global Regulatory Services (GRS) announces strategic alliance with CONUSBAT

With the current EU Cosmetics Directive becoming the Cosmetic Products Regulation, fully enforceable in July 2013, GRS can envisage that many existing and new Cosmetic companies will need support to ensure full compliance by next year's deadline.  Therefore, the Directors felt it was important to link up with another like-minded consultancy who specialise in the Cosmetic Industry.  With GRS' expertise in borderline products (such as herbals) and the focused specialism of CONUSBAT on Cosmetics, the combination will be of tremendous value to Cosmetic companies.

Abcam, a GRS client, is the next "rising star"

Sir Christopher Evans opened the One Nucleus Bench-to-Boardroom event on 6th March.  His popularity could be seen by the fact that it was 'standing room' only for those not quick enough to capture a seat.  He is often described as the ‘founding father’ of the Cambridge biotech cluster and it was clear that Cambridge remains a special place for him.

Press Release: New EU herbal remedy laws need urgent review

PRESS RELEASE

14 March 2012

New EU herbal remedy laws need urgent review, warns
Global Regulatory Services

A regulatory consultancy for the herbal industry is urging EU health officials to review new laws which came into force in April last year, warning that it is being flouted by a number of companies to avoid its costly licensing process, and that its future in Europe is at risk.

GRS Directors meet Professor Sir Christopher Evans at One Nucleus Bench-to-Boardroom event, 6th March 2012


From Left to Right: Bobby Deal, Managing Director (GRS), Professor Sir Christopher Evans, Greer Deal, Director (GRS) (Photograph courtesy of Ellee Seymour, ProActive PR)

Press Release: Research within the NHS – life science companies invited to share their thoughts and experiences

Innovative life science companies are invited to share their thoughts and experiences about research within the NHS at a One Nucleus workshop in Newmarket next month.

It will be led by Greer Deal, Director of Global Regulatory Services, who will provide examples and case studies to demonstrate how the private sector can work successfully with the public sector.

Virgin Health Bank are setting up in Cambridge (UK)

GRS is delighted with the announcement in January 2012 that the Virgin Health Bank (cord blood banking) has established a long term partnership with the Cambridge University Hospitals NHS Foundation Trust.  The aim of the partnership is to accelerate the development and availability of stem cell transplants.  It is also hoped that this collaboration will show case how the private and public sector can work together successfully.